Lisa Doherty

2.5k total citations
40 papers, 1.4k citations indexed

About

Lisa Doherty is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lisa Doherty has authored 40 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Genetics, 12 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lisa Doherty's work include Glioma Diagnosis and Treatment (33 papers), Brain Metastases and Treatment (10 papers) and Cancer Treatment and Pharmacology (7 papers). Lisa Doherty is often cited by papers focused on Glioma Diagnosis and Treatment (33 papers), Brain Metastases and Treatment (10 papers) and Cancer Treatment and Pharmacology (7 papers). Lisa Doherty collaborates with scholars based in United States, Switzerland and Australia. Lisa Doherty's co-authors include Patrick Y. Wen, Jan Drappatz, Santosh Kesari, Andrew D. Norden, A. S. Ciampa, Debra C. LaFrankie, Alona Muzikansky, David Schiff, E. C. Quant and Tracy T. Batchelor and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Diabetes Care.

In The Last Decade

Lisa Doherty

40 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa Doherty United States 18 814 445 323 309 247 40 1.4k
Sandra Tourt-Uhlig United States 10 807 1.0× 507 1.1× 358 1.1× 232 0.8× 269 1.1× 12 1.3k
David B. Mansur United States 21 633 0.8× 230 0.5× 421 1.3× 205 0.7× 210 0.9× 82 1.5k
Miguel Gil‐Gil Spain 23 600 0.7× 322 0.7× 619 1.9× 396 1.3× 814 3.3× 101 1.7k
Adele Caldarella Italy 25 285 0.4× 240 0.5× 374 1.2× 200 0.6× 499 2.0× 71 1.6k
Francesca Diomedi‐Camassei Italy 21 293 0.4× 628 1.4× 265 0.8× 143 0.5× 147 0.6× 106 1.6k
Scott Cruickshank United States 21 582 0.7× 741 1.7× 1.0k 3.2× 368 1.2× 1.2k 4.9× 56 2.6k
Hiroyuki Eguchi Japan 17 268 0.3× 664 1.5× 142 0.4× 173 0.6× 203 0.8× 25 1.3k
J. G. Cairncross Canada 10 1.3k 1.6× 253 0.6× 652 2.0× 228 0.7× 213 0.9× 11 1.7k
W. Paul Bowman United States 26 325 0.4× 348 0.8× 218 0.7× 126 0.4× 336 1.4× 50 2.1k
Monika Hackl Austria 18 325 0.4× 325 0.7× 636 2.0× 132 0.4× 1.0k 4.1× 40 1.7k

Countries citing papers authored by Lisa Doherty

Since Specialization
Citations

This map shows the geographic impact of Lisa Doherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Doherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Doherty more than expected).

Fields of papers citing papers by Lisa Doherty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Doherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Doherty. The network helps show where Lisa Doherty may publish in the future.

Co-authorship network of co-authors of Lisa Doherty

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Doherty. A scholar is included among the top collaborators of Lisa Doherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Doherty. Lisa Doherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doherty, Lisa, et al.. (2025). Qualitative findings on consumer awareness of recommendations for effective sunscreen application. Australian and New Zealand Journal of Public Health. 49(5). 100253–100253. 1 indexed citations
2.
Lee, Eudocia Q., Dan G. Duda, Alona Muzikansky, et al.. (2018). Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma. Clinical Cancer Research. 24(19). 4643–4649. 49 indexed citations
3.
Norden, Andrew D., Jan Drappatz, Surasak Phuphanich, et al.. (2014). Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma: Final results.. Journal of Clinical Oncology. 32(15_suppl). 2027–2027. 1 indexed citations
4.
Rahman, Rifaquat, Andrew D. Norden, David A. Reardon, et al.. (2014). Retrospective study of carmustine or lomustine with bevacizumab in recurrent glioblastoma patients who have failed prior bevacizumab. Neuro-Oncology. 16(11). 1523–1529. 19 indexed citations
5.
Smith, Katrina H., Eudocia Q. Lee, Alona Muzikansky, et al.. (2014). Phase I study of plerixafor and bevacizumab in recurrent high-grade glioma.. Journal of Clinical Oncology. 32(15_suppl). 2031–2031. 1 indexed citations
6.
Lee, Eudocia Q., Lakshmi Nayak, Lisa Doherty, et al.. (2013). Retrospective study of pemetrexed as salvage therapy for central nervous system lymphoma. Journal of Neuro-Oncology. 115(1). 71–77. 27 indexed citations
7.
Ali, Mohammed, Fabrizio Schifano, Paul Robinson, et al.. (2012). Impact of community pharmacy diabetes monitoring and education programme on diabetes management: a randomized controlled study. Diabetic Medicine. 29(9). e326–33. 98 indexed citations
8.
Norden, Andrew D., Shota Tanaka, Jan Drappatz, et al.. (2011). Safety of concurrent bevacizumab therapy and anticoagulation in glioma patients. Journal of Neuro-Oncology. 106(1). 121–125. 71 indexed citations
9.
Drappatz, Jan, E. Q. Lee, Samantha N. Hammond, et al.. (2011). Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma. Journal of Neuro-Oncology. 107(1). 133–138. 62 indexed citations
10.
Drappatz, Jan, Jeffrey J. Raizer, David Schiff, et al.. (2011). A phase I trial of LBH589 and bevacizumab for recurrent high-grade glioma (HGG).. Journal of Clinical Oncology. 29(15_suppl). 2050–2050. 6 indexed citations
11.
Doherty, Lisa & Debra C. LaFrankie. (2010). Patient Safety Concerns for Cognitively Impaired Patients With Brain Tumors. Clinical journal of oncology nursing. 14(1). 101–102. 1 indexed citations
12.
Drappatz, Jan, Andrew D. Norden, Eric T. Wong, et al.. (2010). Phase I Study of Vandetanib With Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 78(1). 85–90. 68 indexed citations
13.
Lu‐Emerson, Christine, Andrew D. Norden, Jan Drappatz, et al.. (2010). Retrospective study of dasatinib for recurrent glioblastoma after bevacizumab failure. Journal of Neuro-Oncology. 104(1). 287–291. 54 indexed citations
14.
Quant, E. C., Andrew D. Norden, Jan Drappatz, et al.. (2009). Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab. Neuro-Oncology. 11(5). 550–555. 141 indexed citations
15.
Drappatz, Jan, Andrew D. Norden, Eric T. Wong, et al.. (2009). Phase I study of vandetanib with radiation therapy and temozolomide for newly diagnosed glioblastoma. Journal of Clinical Oncology. 27(15_suppl). 2031–2031. 2 indexed citations
16.
Kesari, Santosh, David Schiff, John W. Henson, et al.. (2008). Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults. Neuro-Oncology. 10(3). 300–308. 80 indexed citations
17.
Norden, Andrew D., Jan Drappatz, A. S. Ciampa, et al.. (2008). Colon perforation during antiangiogenic therapy for malignant glioma. Neuro-Oncology. 11(1). 92–95. 16 indexed citations
18.
Drappatz, Jan, Eric T. Wong, David Schiff, et al.. (2008). A Pilot Safety Study of Lenalidomide and Radiotherapy for Patients With Newly Diagnosed Glioblastoma Multiforme. International Journal of Radiation Oncology*Biology*Physics. 73(1). 222–227. 42 indexed citations
19.
Kesari, Santosh, David Schiff, Lisa Doherty, et al.. (2007). Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults. Neuro-Oncology. 9(3). 354–363. 92 indexed citations
20.
Wen, Patrick Y., et al.. (2006). Medical management of patients with brain tumors. Journal of Neuro-Oncology. 80(3). 313–332. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandra Tourt-Uhlig Breakdown of academic impact, for papers by David B. Mansur Breakdown of academic impact, for papers by Miguel Gil‐Gil Breakdown of academic impact, for papers by Adele Caldarella Breakdown of academic impact, for papers by Francesca Diomedi‐Camassei Breakdown of academic impact, for papers by Scott Cruickshank Breakdown of academic impact, for papers by Hiroyuki Eguchi Breakdown of academic impact, for papers by J. G. Cairncross Breakdown of academic impact, for papers by W. Paul Bowman Breakdown of academic impact, for papers by Monika Hackl
Rankless by CCL
2026